Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and open status for the NIH Clinical Center, plus a new version tag v3.2.0; removed the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T07:00:19.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:48:08.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Location listings and date markers updated: new sites and September 2025 entries added; older or specific location records removed.
    Difference
    3%
    Check dated 2025-09-22T00:24:00.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Updates include new registry identifiers, a new document version (v3.0.2), clearer timing for the last update, and migration of access materials to new URLs, replacing older EngageZone links.
    Difference
    2%
    Check dated 2025-09-14T21:51:57.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T18:47:47.000Z thumbnail image
  8. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of various facility names and locations across multiple countries, while also removing outdated location references and some medical topics. Notably, the revision number has been updated to v3.0.0.
    Difference
    8%
    Check dated 2025-08-31T12:20:18.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.